Article 6AXR7 The Supreme Court battle over the abortion pill and FDA authority, explained [Updated]

The Supreme Court battle over the abortion pill and FDA authority, explained [Updated]

by
Beth Mole
from Ars Technica - All content on (#6AXR7)
GettyImages-1251856300-800x515.jpeg

Enlarge / Demonstrators rally in support of abortion rights at the US Supreme Court in Washington, DC, on April 15, 2023. (credit: Getty | NDREW CABALLERO-REYNOLDS )

Update 4/19/2023 3:58 pm ET: Supreme Court Justice Samuel Alito extended the temporary stay on the lower court's order. It is now stayed until midnight on Friday, April 21, 2023. The stay preserves the status quo access to the abortion and miscarriage drug mifepristone for two more days.

Original story 4/18/2023 11:09 pm ET: The US Supreme Court may soon issue a ruling in a high-stakes case that will determine not only the national availability of the safe and effective abortion and miscarriage medication mifepristone but also the fate of the Food and Drug Administration's overall authority to regulate the country's drugs.

In case you haven't been following along, here's everything you need to know before the high court makes its next move.

Read 46 remaining paragraphs | Comments

External Content
Source RSS or Atom Feed
Feed Location http://feeds.arstechnica.com/arstechnica/index
Feed Title Ars Technica - All content
Feed Link https://arstechnica.com/
Reply 0 comments